Tesla has accelerated Optimus humanoid robot production at its Fremont factory, scaling from dozens of units weekly in Q2 2026 to several hundred by August, with internal targets exceeding 1,000 per week by year-end through an automated line. This ramp supports data collection for training large language model-based control systems, yet persistent challenges remain in AI generalization, task learning speed, and hand dexterity reliability, limiting robots to supervised internal use rather than broad deployment. Elon Musk has targeted public sales by late 2027 contingent on high reliability and functionality, though promised mid-2026 Gen 3 demonstrations have slipped. Competitive pressure from firms like XPeng and historical timeline misses continue to shape trader views on near-term commercial release thresholds.